AHA Statement on Lower Drug Costs Now Act

Tom Nickels
Executive Vice President
American Hospital Association

September 19, 2019

The American Hospital Association applauds today’s proposal that takes significant strides toward reducing out-of-control drug prices, which continue to place patients and the providers who care for them at risk. Outrageous drug prices force too many patients into rationing their drugs or leaving their prescriptions unfilled. America’s hospitals and health systems see the consequences first hand: patients coming back through our doors sicker than when they left. Not only do our patients feel it at the pharmacy counter, but the high cost of drugs threatens the ability of hospitals and health systems to acquire needed drugs for patients in their care.

We look forward to further reviewing today’s proposal and continuing to work with the Administration and the Congress to make progress on lowering drug prices.


Contact:     Colin Milligan, (202) 638-5491
                   Marie Johnson, (202) 626-2351

Related Resources

AHA urges the Centers for Medicare…
Special Bulletin
The Centers for Medicare & Medicaid Services (CMS) Nov. 20 released an interim final rule implementing the Most Favored Nation (MFN) Model, a new payment…
AHA Center for Health Innovation Market Scan
Intermountain Healthcare has agreed to sell its Intalere group purchasing organization (formerly Amerinet) to Vizient, a GPO that also provides data analytics…
Action Alert
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Department of Health and Human Services Secretary…
Fact Sheets
The Issue: Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at…
Special Bulletin
Summary of President Trump’s executive order to address drug pricing via “most-favored-nation” pricing model.